424 related articles for article (PubMed ID: 26305546)
1. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.
Huang YH; Kuo HC; Yang YL; Wang FS
Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801
[TBL] [Abstract][Full Text] [Related]
4. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries.
Li SC; Wang FS; Yang YL; Tiao MM; Chuang JH; Huang YH
Int J Mol Sci; 2016 Mar; 17(3):324. PubMed ID: 26938532
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway.
Tiao MM; Wang FS; Huang LT; Chuang JH; Kuo HC; Yang YL; Huang YH
Apoptosis; 2014 Jan; 19(1):30-41. PubMed ID: 24052410
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice.
Huang YH; Yang YL; Huang FC; Tiao MM; Lin YC; Tsai MH; Wang FS
Exp Biol Med (Maywood); 2018 Jan; 243(1):13-21. PubMed ID: 29105510
[TBL] [Abstract][Full Text] [Related]
7. Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype.
Chou MH; Huang YH; Lin TM; Du YY; Tsai PC; Hsieh CS; Chuang JH
Biochem J; 2012 Oct; 447(1):25-34. PubMed ID: 22765640
[TBL] [Abstract][Full Text] [Related]
8. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
Fu J; Wu B; Zhong S; Deng W; Lin F
Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice.
Lin YC; Wang FS; Yang YL; Chuang YT; Huang YH
Biochem Biophys Res Commun; 2018 Feb; 496(3):880-886. PubMed ID: 29366780
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation.
Chen C; Wu CQ; Zhang ZQ; Yao DK; Zhu L
Exp Cell Res; 2011 Jul; 317(12):1714-25. PubMed ID: 21586285
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
14. Hepatic stellate cell-specific deletion of SIRT1 exacerbates liver fibrosis in mice.
Li M; Hong W; Hao C; Li L; Xu H; Li P; Xu Y
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3202-3211. PubMed ID: 28919365
[TBL] [Abstract][Full Text] [Related]
15. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.
Hu J; Chen C; Liu Q; Liu B; Song C; Zhu S; Wu C; Liu S; Yu H; Yao D; Kang J; Zhu L
Clin Sci (Lond); 2015 Aug; 129(4):305-17. PubMed ID: 25728779
[TBL] [Abstract][Full Text] [Related]
16. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.
Kennedy LL; Meng F; Venter JK; Zhou T; Karstens WA; Hargrove LA; Wu N; Kyritsi K; Greene J; Invernizzi P; Bernuzzi F; Glaser SS; Francis HL; Alpini G
Lab Invest; 2016 Dec; 96(12):1256-1267. PubMed ID: 27775690
[TBL] [Abstract][Full Text] [Related]
17. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
Yang YL; Wang FS; Lin HY; Huang YH
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29a ameliorates glucocorticoid-induced suppression of osteoblast differentiation by regulating β-catenin acetylation.
Ko JY; Chuang PC; Chen MW; Ke HC; Wu SL; Chang YH; Chen YS; Wang FS
Bone; 2013 Dec; 57(2):468-75. PubMed ID: 24096265
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
[TBL] [Abstract][Full Text] [Related]
20. The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis.
Huang YH; Yang YL; Wang FS
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
